SIMCERE PHARMACEUTICAL GROUP Stockholders' Equity Attributable to Noncontrolling Interest
SIMCERE PHARMACEUTICAL GROUP had Stockholders' Equity Attributable to Noncontrolling Interest of CNY 60.24 million as of 2012-12-31, per its 20-F filed 2013-04-26.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest
us-gaap:MinorityInterest · last filed 2013-04-26
- 2012-12-31: Stockholders' Equity Attributable to Noncontrolling Interest 60.24M CNY.
- 2011-12-31: Stockholders' Equity Attributable to Noncontrolling Interest 137.52M CNY.
- 2010-12-31: Stockholders' Equity Attributable to Noncontrolling Interest 175.57M CNY.
CNY
| Period end | Stockholders' Equity Attributable to Noncontrolling Interest |
|---|---|
| 2012-12-31 | 60.24M CNY 20-F · filed 2013-04-26 |
| 2011-12-31 | 137.52M CNY 20-F · filed 2013-04-26 |
| 2010-12-31 | 175.57M CNY 20-F · filed 2012-04-25 |
USD
| Period end | Stockholders' Equity Attributable to Noncontrolling Interest |
|---|---|
| 2012-12-31 | $9.67M 20-F · filed 2013-04-26 |